Liposomes as Potential Drug Carrier Systems for Drug Delivery

Lipids are amphiphilic molecules, where one part of the molecule is water-loving (hydrophilic) and the other water-hating (hydrophobic). When lipids are placed in contact with water, the unfavorable interactions of the hydrophobic segments of the molecule with the solvent result in the self assembly of lipids, often in the form of liposomes. Liposomes consist of an aqueous core surrounded by a lipid bilayer, much like a membrane, separating the inner aqueous core from the bulk outside. They were first discovered by Bangham and his co-workers in 1961 [1] and described as swollen phospholipid systems [2]. In the following years, a variety of enclosed phospholipid bilayer structures were defined which were initially called bangosomes and then liposomes, which was derived by the combination of two Greek words, “lipos” meaning fat and “soma” meaning body.

[1]  N. Ostrowsky Liposome size measurements by photon correlation spectroscopy , 1993 .

[2]  M. Bally,et al.  Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. , 1990, Biochimica et biophysica acta.

[3]  Q. Ping,et al.  Lecithin vesicular carriers for transdermal delivery of cyclosporin A. , 2000, International journal of pharmaceutics.

[4]  H. Miura,et al.  Improvement of encapsulation efficiency of water-soluble drugs in liposomes formed by the freeze-thawing method. , 1985, Chemical & pharmaceutical bulletin.

[5]  Joel Fried,et al.  Polymer Science and Technology , 1995 .

[6]  A. Ludwig,et al.  The use of mucoadhesive polymers in ocular drug delivery. , 2005, Advanced drug delivery reviews.

[7]  R. Müller,et al.  Solid lipid nanoparticles (SLN) for controlled drug delivery. I. Production, characterization and sterilization , 1994 .

[8]  S. Balasubramanian,et al.  Preparation and characterization of taxane-containing liposomes. , 2005, Methods in enzymology.

[9]  T. Lodge,et al.  Temperature dependence of dynamic light scattering in the intermediate momentum transfer region , 1983 .

[10]  D. Engelman,et al.  Bilayer interactions of pHLIP, a peptide that can deliver drugs and target tumors. , 2008, Biophysical journal.

[11]  Ming-Ren Toh,et al.  Liposomes as sterile preparations and limitations of sterilisation techniques in liposomal manufacturing , 2013 .

[12]  G. Patel,et al.  Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems. , 1999, Critical reviews in biotechnology.

[13]  D. Hinton,et al.  Simultaneous measurement of vesicle diffusion coefficients and trapping efficiencies by means of diffusion ordered 2D NMR spectroscopy. , 1994, Chemistry and physics of lipids.

[14]  P. Cullis,et al.  Factors influencing uptake and retention of amino-containing drugs in large unilamellar vesicles exhibiting transmembrane pH gradients. , 1999, Biochimica et biophysica acta.

[15]  C. Alving,et al.  Complement-Dependent Phagocytosis of Liposomes: Suppression by “Stealth” Lipids , 1992 .

[16]  V. Torchilin,et al.  Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo , 1991, FEBS letters.

[17]  S. Jain,et al.  Ethosomes : A Novel Vesicular Carrier For Enhanced Transdermal Delivery Of An AntiHIV Agent , 2004 .

[18]  E. Korn,et al.  Single bilayer liposomes prepared without sonication. , 1973, Biochimica et biophysica acta.

[19]  W. Lorenz,et al.  Histamine release in dogs by Cremophor El® and its derivatives: Oxethylated oleic acid is the most effective constituent , 1977, Agents and Actions.

[20]  Jian Chen,et al.  Investigation of archaeosomes as carriers for oral delivery of peptides. , 2010, Biochemical and biophysical research communications.

[21]  I. Kellaway,et al.  Poloxamer sorption on liposomes: comparison with polystyrene latex and influence on solute efflux , 1988 .

[22]  B. Rouse,et al.  Target-sensitive immunoliposomes: preparation and characterization. , 1986, Biochemistry.

[23]  T. Anchordoquy,et al.  Maintenance of transfection rates and physical characterization of lipid/DNA complexes after freeze-drying and rehydration. , 1997, Archives of biochemistry and biophysics.

[24]  R. W. Baldwin,et al.  Adsorption of monoclonal antibodies to polyhexylcyanoacrylate nanoparticles and subsequent immunospecific binding to tumour cells in vitro , 1983 .

[25]  Rakesh K. Sharma,et al.  Tumoricidal effects of etoposide incorporated into solid lipid nanoparticles after intraperitoneal administration in Dalton's lymphoma bearing mice , 2006, The AAPS Journal.

[26]  Manuel Alatorre-Meda,et al.  DNA-METAFECTENE PRO complexation: a physical chemistry study. , 2010, Physical chemistry chemical physics : PCCP.

[27]  Y. Rustum,et al.  Inhibition of tumor cell growth in vitro and in vivo by 1-beta-D-arabinofuranosylcytosine entrapped within phospholipid vesicles. , 1976, Cancer research.

[28]  T. Dutta,et al.  Dermal and transdermal delivery of an anti-psoriatic agent via ethanolic liposomes. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[29]  T. Anchordoquy,et al.  Maintenance of nonviral vector particle size during the freezing step of the lyophilization process is insufficient for preservation of activity: insight from other structural indicators. , 2001, Journal of pharmaceutical sciences.

[30]  U. Pick,et al.  Liposomes with a large trapping capacity prepared by freezing and thawing of sonicated phospholipid mixtures. , 1981, Archives of biochemistry and biophysics.

[31]  S. Tsukagoshi,et al.  Enhancement of the cancer chemotherapeutic effect of cytosine arabinoside entrapped in liposomes on mouse leukemia L-1210. , 1975, Gan.

[32]  F. Dosio,et al.  Poly(ethylene glycol)-human serum albumin-paclitaxel conjugates: preparation, characterization and pharmacokinetics. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[33]  J. Wilschut,et al.  Delivery of Protein Antigens to the Immune System by Fusion-Active Virosomes: A Comparison with Liposomes and ISCOMs , 2002, Bioscience reports.

[34]  B. Godin,et al.  Ethosomes - novel vesicular carriers for enhanced delivery: characterization and skin penetration properties. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[35]  S. Feng,et al.  Preparation and characterization of poly(lactic acid)-poly(ethylene glycol)-poly(lactic acid) (PLA-PEG-PLA) microspheres for controlled release of paclitaxel. , 2003, Biomaterials.

[36]  Massimo Fresta,et al.  Ethosomes for skin delivery of ammonium glycyrrhizinate: in vitro percutaneous permeation through human skin and in vivo anti-inflammatory activity on human volunteers. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[37]  K. Hande,et al.  Etoposide: four decades of development of a topoisomerase II inhibitor. , 1998, European journal of cancer.

[38]  J. Hadgraft,et al.  Evaluation of Mucoadhesive Polymers in Ocular Drug Delivery. II. Polymer-Coated Vesicles , 1992, Pharmaceutical Research.

[39]  Vladimir P Torchilin,et al.  Nanopreparations for organelle-specific delivery in cancer. , 2014, Advanced drug delivery reviews.

[40]  Kazuo Maruyama,et al.  Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes , 1990, FEBS letters.

[41]  G. Gahrton,et al.  Treatment of acute leukemia--advances in chemotherapy, immunotherapy, and bone marrow transplantation. , 1983, Advances in cancer research.

[42]  Y. Kaneda,et al.  Virosomes: evolution of the liposome as a targeted drug delivery system. , 2000, Advanced drug delivery reviews.

[43]  M. Hope,et al.  Antibacterial Efficacy against an In Vivo Salmonella typhimurium Infection Model and Pharmacokinetics of a Liposomal Ciprofloxacin Formulation , 1998, Antimicrobial Agents and Chemotherapy.

[44]  V. Torchilin,et al.  Amphiphilic vinyl polymers effectively prolong liposome circulation time in vivo. , 1994, Biochimica et biophysica acta.

[45]  D. Crommelin,et al.  The preparation of tissue-type Plasminogen Activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage. , 1995, Journal of drug targeting.

[46]  C. Ehrhardt,et al.  Inhaled Liposomes–Current Strategies and Future Challenges , 2008 .

[47]  A A Bogdanov,et al.  Poly(ethylene glycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. , 1994, Biochimica et biophysica acta.

[48]  M. T. ten Kate,et al.  Improved Efficacy of Ciprofloxacin Administered in Polyethylene Glycol-Coated Liposomes for Treatment of Klebsiella pneumoniae Pneumonia in Rats , 2001, Antimicrobial Agents and Chemotherapy.

[49]  S. Vyas,et al.  Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis , 2007, Journal of drug targeting.

[50]  V. Usonis,et al.  Antibody titres after primary and booster vaccination of infants and young children with a virosomal hepatitis A vaccine (Epaxal). , 2003, Vaccine.

[51]  J. Watkins,et al.  Suspected anaphylactic reaction to Cremophor EL. , 1980, British medical journal.

[52]  José Villalaín,et al.  Influence of liposome charge and composition on their interaction with human blood serum proteins , 1993, Molecular and Cellular Biochemistry.

[53]  D. Papahadjopoulos,et al.  Medical applications of liposomes , 1998 .

[54]  D. Kingston,et al.  Design, synthesis, and bioactivities of steroid-linked taxol analogues as potential targeted drugs for prostate and breast cancer. , 2004, Journal of natural products.

[55]  S. A. Kramer,et al.  Effect of povidone-iodine on wound healing: a review. , 1999, Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing.

[56]  J. Wilschut,et al.  Influenza virosomes in vaccine development. , 2003, Methods in enzymology.

[57]  G. Cevc Drug-Carrier and Stability Properties of the Long-Lived Lipid Vesicles. Cryptosomes, in Vitro and in Vivo , 1992 .

[58]  P. Cullis,et al.  Anomalous solubility behavior of the antibiotic ciprofloxacin encapsulated in liposomes: a 1H-NMR study. , 1998, Biochimica et biophysica acta.

[59]  J. Huwyler,et al.  Brain drug delivery of small molecules using immunoliposomes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[60]  J. Rogers,et al.  Polymer-coated liposomes; stability and release of ASA from carboxymethyl chitin-coated liposomes , 1991 .

[61]  Adrian C. Williams,et al.  Transdermal and Topical Drug Delivery : From Theory to Clinical Practice , 2003 .

[62]  D. Lasič,et al.  Doxorubicin in sterically stabilized liposomes , 1996, Nature.

[63]  J. Reuben,et al.  Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. , 1985, The Journal of infectious diseases.

[64]  R. Straubinger,et al.  Antitumor effect of taxol-containing liposomes in a taxol-resistant murine tumor model. , 1993, Cancer research.

[65]  R. New,et al.  Liposomes : a practical approach , 1990 .

[66]  N. Bressler Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. , 2002, American journal of ophthalmology.

[67]  V. Torchilin Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[68]  G Gregoriadis,et al.  Drug entrapment in liposomes , 1973, FEBS letters.

[69]  E. Eliav,et al.  A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. , 1999, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[70]  S. Balasubramanian,et al.  Pharmaceutical and physical properties of paclitaxel (Taxol) complexes with cyclodextrins. , 1995, Journal of pharmaceutical sciences.

[71]  J. S. Dua,et al.  LIPOSOME: METHODS OF PREPARATION AND APPLICATIONS , 2012 .

[72]  A. Gabizon,et al.  The role of surface charge and hydrophilic groups on liposome clearance in vivo. , 1992, Biochimica et biophysica acta.

[73]  J. Hubbell,et al.  Solution technique to incorporate polyethylene oxide and other water-soluble polymers into surfaces of polymeric biomaterials. , 1991, Biomaterials.

[74]  P I Campbell,et al.  Toxicity of some charged lipids used in liposome preparations. , 1983, Cytobios.

[75]  F. Szoka,et al.  Preparation of unilamellar liposomes of intermediate size (0.1-0.2 mumol) by a combination of reverse phase evaporation and extrusion through polycarbonate membranes. , 1980, Biochimica et biophysica acta.

[76]  G Gregoriadis,et al.  The carrier potential of liposomes in biology and medicine (second of two parts). , 1976, The New England journal of medicine.

[77]  D. Lasič Novel applications of liposomes. , 1998, Trends in biotechnology.

[78]  P. Bharat,et al.  A COMPLETE REVIEW ON : LIPOSOMES , 2012 .

[79]  N. Van Rooijen,et al.  Liposomes in immunology: multilamellar phosphatidylcholine liposomes as a simple, biodegradable and harmless adjuvant without any immunogenic activity of its own. , 1980, Immunological communications.

[80]  J. Puskin,et al.  A spin label method for measuring internal volumes in liposomes or cells, applied to Ca-dependent fusion of negatively charged vesicles. , 1981, Biochimica et biophysica acta.

[81]  D. Lasič,et al.  Liposomes: From Physics to Applications , 1993 .

[82]  Amarnath Sharma,et al.  Liposomes in drug delivery: Progress and limitations , 1997 .

[83]  Joseph A. Zasadzinski,et al.  Nanocompartments Enclosing Vesicles, Colloids, and Macromolecules via Interdigitated Lipid Bilayers , 2002 .

[84]  M. Woodle,et al.  Sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.

[85]  J. Viret,et al.  Virosomal adjuvanted antigen delivery systems , 2003, Expert review of vaccines.

[86]  L. Mayer,et al.  Liposomal and nonliposomal drug pharmacokinetics after administration of liposome-encapsulated vincristine and their contribution to drug tissue distribution properties. , 2001, The Journal of pharmacology and experimental therapeutics.

[87]  F. Levi-Schaffer,et al.  Intracellular delivery mediated by an ethosomal carrier. , 2001, Biomaterials.

[88]  M. Bally,et al.  Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. , 1985, Biochimica et biophysica acta.

[89]  J. Patton Inhalation delivery of therapeutic peptides and proteins. , 1999, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[90]  Yingjin Yuan,et al.  Synthesis and evaluation of water-soluble paclitaxel prodrugs. , 2002, Bioorganic & medicinal chemistry letters.

[91]  P. Rougé,et al.  Modes of membrane interaction of a natural cysteine-rich peptide: viscotoxin A3. , 2002, Biochimica et biophysica acta.

[92]  Y. Barenholz,et al.  Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. , 1989, European journal of cancer & clinical oncology.

[93]  R. Donehower,et al.  Drug therapy : paclitaxel (Taxol) , 1995 .

[94]  P. Lambelet,et al.  The fate of antioxidant radicals during lipid autooxidation. I. The tocopheroxyl radicals. , 1984, Chemistry and physics of lipids.

[95]  Mayank M. Patel,et al.  The stability of lyophilized lipid/DNA complexes during prolonged storage. , 2004, Journal of pharmaceutical sciences.

[96]  D. Needham,et al.  The "Stealth" Liposome: A Prototypical Biomaterial , 1995 .

[97]  M. Nakano,et al.  Clinical Pharmacokinetics of Cytarabine Formulations , 2002, Clinical pharmacokinetics.

[98]  A. R. Fernandes,et al.  Application of Nanotechnology in Drug Delivery , 2014 .

[99]  G. Betageri,et al.  Factors affecting microencapsulation of drugs in liposomes. , 1995, Journal of microencapsulation.

[100]  F. Szoka,et al.  Preparation of liposomes of defined size distribution by extrusion through polycarbonate membranes. , 1979, Biochimica et biophysica acta.

[101]  Zhuo Georgia Chen,et al.  Advances of cancer therapy by nanotechnology. , 2009, Cancer research and treatment : official journal of Korean Cancer Association.

[102]  G. Gregoriadis,et al.  Liposomes and cancer therapy. , 1991, Cancer cells.

[103]  F. Frézard,et al.  Liposomes: from biophysics to the design of peptide vaccines. , 1999, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[104]  P. Beaumier,et al.  Effects of liposome size on the degradation of bovine brain sphingomyelin/cholesterol liposomes in the mouse liver. , 1983, Biochimica et biophysica acta.

[105]  D. P. Sarkar,et al.  Targeted gene delivery by virosomes. , 2002, Methods in molecular biology.

[106]  J. Zasadzinski,et al.  Encapsulating vesicles and colloids from cochleate cylinders , 2003 .

[107]  F. Martin,et al.  Pharmacokinetics and antitumor activity of epirubicin encapsulated in long‐circulating liposomes incorporating a polyethylene glycol‐derivatized phospholipid , 1992, International journal of cancer.

[108]  J. Akbuǧa,et al.  Encapsulation of Enrofloxacin in Liposomes I: Preparation and In Vitro Characterization of LUV , 2004, Journal of liposome research.

[109]  R. Fielding Liposomal Drug Delivery , 1991, Clinical pharmacokinetics.

[110]  G. Patel,et al.  In vitro assessment of archaeosome stability for developing oral delivery systems. , 2000, International journal of pharmaceutics.

[111]  S. Kawakami,et al.  Prednisolone retention in integrated liposomes by chemical approach and pharmaceutical approach. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[112]  L. Packer,et al.  [89] Measurements of volumes and electrochemical gradients with spin probes in membrane vesicles , 1982 .

[113]  B. W. Barry,et al.  Novel mechanisms and devices to enable successful transdermal drug delivery. , 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[114]  J. D. de Pablo,et al.  Effect of sugar-phosphate mixtures on the stability of DPPC membranes in dehydrated systems. , 2004, Cryobiology.

[115]  J. Fendler,et al.  Liposomes as drug carriers. , 1977, Life sciences.

[116]  A. Driessen,et al.  The stability and functional properties of proteoliposomes mixed with dextran derivatives bearing hydrophobic anchor groups. , 1992, Biochimica et biophysica acta.

[117]  D. Wallach,et al.  Some properties of N-acyl sarcosinate lipid vesicles , 1992 .

[118]  A. El‐Kattan,et al.  Enhancement of transdermal drug delivery: chemical and physical approaches. , 2000, Critical reviews in therapeutic drug carrier systems.

[119]  L. Mayer,et al.  Solute distributions and trapping efficiencies observed in freeze-thawed multilamellar vesicles. , 1985, Biochimica et biophysica acta.

[120]  Agustina Gómez-Hens,et al.  Analytical methods for the control of liposomal delivery systems , 2006 .

[121]  M. Malmsten,et al.  Effect of lipid headgroup composition on the interaction between melittin and lipid bilayers. , 2007, Journal of colloid and interface science.

[122]  R. Devraj,et al.  Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. , 2002, Journal of colloid and interface science.

[123]  A. Misra,et al.  Ethosomes: a novel delivery system for antifungal drugs in the treatment of topical fungal diseases. , 2009, Indian journal of experimental biology.

[124]  G Blume,et al.  Molecular mechanism of the lipid vesicle longevity in vivo. , 1993, Biochimica et biophysica acta.

[125]  M. Hashida,et al.  An application of water-in-oil and gelatin-microsphere-in-oil emulsions to specific delivery of anticancer agent into stomach lymphatics , 1977, Journal of Pharmacokinetics and Biopharmaceutics.

[126]  K. Behar,et al.  Determination of liposomal encapsulation efficiency using proton NMR spectroscopy. , 2004, Chemistry and physics of lipids.

[127]  N. Weiner,et al.  The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage , 1996 .

[128]  G. Sprott Structures of archaebacterial membrane lipids , 1992, Journal of bioenergetics and biomembranes.

[129]  K. Katayama,et al.  Improved Drug Delivery to Target Specific Organs Using Liposomes as Coated with Polysaccharides , 1983 .

[130]  D. Arifin,et al.  Determination of Size Distribution and Encapsulation Efficiency of Liposome‐Encapsulated Hemoglobin Blood Substitutes Using Asymmetric Flow Field‐Flow Fractionation Coupled with Multi‐Angle Static Light Scattering , 2003, Biotechnology progress.

[131]  Simon C Watkins,et al.  Lyophilization of cationic lipid-protamine-DNA (LPD) complexes. , 2000, Journal of pharmaceutical sciences.

[132]  Y. Mizushima,et al.  Use of a lipid emulsion as a novel carrier for corticosteroids , 1982, The Journal of pharmacy and pharmacology.

[133]  A. Manosroi,et al.  Characterization of Amphotericin B Liposome Formulations , 2004, Drug development and industrial pharmacy.

[134]  F. Dehghani,et al.  Conventional and Dense Gas Techniques for the Production of Liposomes: A Review , 2008, AAPS PharmSciTech.

[135]  T. Yonetani,et al.  Preparation and characterization of liposome-encapsulated haemoglobin by a freeze-thaw method. , 1994, Journal of microencapsulation.

[136]  D. Deamer,et al.  Large volume liposomes by an ether vaporization method. , 1976, Biochimica et biophysica acta.

[137]  V. Torchilin,et al.  Targeted accumulation of polyethylene glycol‐coated immunoliposomes in infarcted rabbit myocardium , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[138]  G. Feigenson,et al.  A novel strategy for the preparation of liposomes: rapid solvent exchange. , 1999, Biochimica et biophysica acta.

[139]  J. Neuzil,et al.  Lyophilised liposome-based formulations of alpha-tocopheryl succinate: preparation and physico-chemical characterisation. , 2010, Journal of pharmaceutical sciences.

[140]  G. Gregoriadis,et al.  Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. , 1980, The Biochemical journal.

[141]  R. Macdonald,et al.  A simple procedure for the determination of the trapped volume of liposomes , 1982 .

[142]  I. Ahmad,et al.  Determination by liquid chromatography with fluorescence detection of total 7-ethyl-10-hydroxy-camptothecin (SN-38) in beagle dog plasma after intravenous administration of liposome-based SN-38 (LE-SN38). , 2003, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[143]  R. Singh,et al.  Recent advances in various emerging vescicular systems: An overview , 2012 .

[144]  E. Fattal,et al.  Use of an enzyme immunoassay for the evaluation of entrapment efficiency and in vitro stability in intestinal fluids of liposomal bovine serum albumin , 1996 .

[145]  Rapid method for determination of residual tert-butanol in liposomes using solid-phase microextraction and gas chromatography. , 2010, Journal of chromatographic science.

[146]  J. Giddings,et al.  Size distribution of liposomes by flow field-flow fractionation. , 1993, Journal of pharmaceutical and biomedical analysis.

[147]  T. Allen,et al.  Stealth liposomes: an improved sustained release system for 1-beta-D-arabinofuranosylcytosine. , 1992, Cancer research.

[148]  Henk-Jan Guchelaar,et al.  Liposomal drug formulations in cancer therapy: 15 years along the road. , 2012, Drug discovery today.

[149]  D. Deamer PREPARATION AND PROPERTIES OF ETHER‐INJECTION LIPOSOMES * , 1978, Annals of the New York Academy of Sciences.

[150]  P. Caliceti,et al.  New synthetic amphiphilic polymers for steric protection of liposomes in vivo. , 1995, Journal of pharmaceutical sciences.

[151]  A. Janoff,et al.  Activity of paclitaxel liposome formulations against human ovarian tumor xenografts , 1997, International journal of cancer.

[152]  R. Biltonen,et al.  The use of differential scanning calorimetry as a tool to characterize liposome preparations , 1993 .

[153]  G. Smolin,et al.  Idoxuridine-liposome therapy for herpes simplex keratitis. , 1981, American journal of ophthalmology.

[154]  G. Hortobagyi,et al.  Risks and Benefits of Taxanes in Breast and Ovarian Cancer , 2000, Drug safety.

[155]  J. Barbeau,et al.  Archaeal tetraether bipolar lipids: Structures, functions and applications. , 2009, Biochimie.

[156]  K. Maruyama,et al.  Effect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilamellar liposomes. , 1991, Chemical & pharmaceutical bulletin.

[157]  K. Gelmon,et al.  Pharmacokinetic behavior of vincristine sulfate following administration of vincristine sulfate liposome injection , 1998, Cancer Chemotherapy and Pharmacology.

[158]  G Gregoriadis,et al.  Engineering liposomes for drug delivery: progress and problems. , 1995, Trends in biotechnology.

[159]  I. Kwon,et al.  Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(ε-caprolactone) copolymer as a carrier for paclitaxel , 2003 .

[160]  Patel Gb,et al.  Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems. , 1999 .

[161]  Q. Xu,et al.  Stability of paclitaxel in 5% dextrose injection or 0.9% sodium chloride injection at 4, 22, or 32 degrees C. , 1994, American journal of hospital pharmacy.

[162]  K. Wasan,et al.  A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[163]  J. Mascola,et al.  HIV-1 neutralizing antibodies in the genital and respiratory tracts of mice intranasally immunized with oligomeric gp160. , 1998, Journal of immunology.

[164]  G. Storm,et al.  Specific targeting with poly(ethylene glycol)-modified liposomes: coupling of homing devices to the ends of the polymeric chains combines effective target binding with long circulation times. , 1993, Biochimica et biophysica acta.

[165]  J. Sunamoto,et al.  Bile salt damage of egg phosphatidylcholine liposomes. , 1985, Biochimica et biophysica acta.

[166]  Patrick Couvreur,et al.  Pharmacokinetics and Distribution of a Biodegradable Drug-carrier , 1983 .

[167]  W. Richter,et al.  Synthetic glycolipids as membrane-bound cryoprotectants in the freezedrying process of liposomes , 1996 .

[168]  M. Schofield,et al.  Cholesterol versus cholesterol sulfate: effects on properties of phospholipid bilayers containing docosahexaenoic acid. , 1998, Chemistry and physics of lipids.

[169]  Jonathan D. Ashley,et al.  Ligand-targeted liposome design: challenges and fundamental considerations. , 2014, Trends in biotechnology.

[170]  B. Leyland-Jones,et al.  Hypersensitivity reactions from taxol. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[171]  V. Labhasetwar,et al.  A study on zeta potential and dielectric constant of liposomes. , 1994, Journal of microencapsulation.

[172]  M. S. Muthu,et al.  Targeted nanomedicines: effective treatment modalities for cancer, AIDS and brain disorders. , 2009, Nanomedicine.

[173]  Sanyog Jain,et al.  Development and characterization of emulsomes for sustained and targeted delivery of an antiviral agent to liver , 2006, The Journal of pharmacy and pharmacology.

[174]  Vladimir P. Torchilin,et al.  Use of polyoxyethylene-lipid conjugates as long-circulating carriers for delivery of therapeutic and diagnostic agents , 1995 .

[175]  S. Vyas,et al.  Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting , 2007, Journal of drug targeting.

[176]  K. P. Rao,et al.  Studies on the carboxymethyl chitosan-containing liposomes for their stability and controlled release of dapsone. , 1991, Journal of microencapsulation.

[177]  B. Godin,et al.  Cannabidiol-transdermal delivery and anti-inflammatory effect in a murine model. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[178]  T. Allen,et al.  Pharmacokinetics of stealth versus conventional liposomes: effect of dose. , 1991, Biochimica et biophysica acta.

[179]  Sérgio Simões,et al.  On the formulation of pH-sensitive liposomes with long circulation times. , 2004, Advanced drug delivery reviews.

[180]  Hesson Chung,et al.  Polymeric micelles of poly(2-ethyl-2-oxazoline)-block-poly(epsilon-caprolactone) copolymer as a carrier for paclitaxel. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[181]  C. Rhodes,et al.  Preparation and characterization of liposomes as therapeutic delivery systems: a review. , 1995, Pharmaceutica acta Helvetiae.

[182]  G. Gregoriadis Overview of liposomes. , 1991, The Journal of antimicrobial chemotherapy.

[183]  V. H. Lee,et al.  Ocular drug bioavailability from topically applied liposomes. , 1985, Survey of ophthalmology.

[184]  R. Glück,et al.  Influenza virosomes as an efficient system for adjuvanted vaccine delivery , 2004, Expert opinion on biological therapy.

[185]  M. Woodle,et al.  Controlling liposome blood clearance by surface-grafted polymers. , 1998, Advanced drug delivery reviews.

[186]  Neil M Bressler,et al.  Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization-verteporfin in photodynamic therapy report 2. , 2002, American journal of ophthalmology.

[187]  J. M. Shaw,et al.  Formulation and Antitumor Activity Evaluation of Nanocrystalline Suspensions of Poorly Soluble Anticancer Drugs , 1996, Pharmaceutical Research.

[188]  T M Allen,et al.  Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. , 1991, Biochimica et biophysica acta.

[189]  V. Torchilin,et al.  p-Nitrophenylcarbonyl-PEG-PE-liposomes: fast and simple attachment of specific ligands, including monoclonal antibodies, to distal ends of PEG chains via p-nitrophenylcarbonyl groups. , 2001, Biochimica et biophysica acta.

[190]  A. Gabizon,et al.  Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[191]  Ulrich Beyer,et al.  Liposomal encapsulated anti-cancer drugs. , 2005, Anti-cancer drugs.

[192]  G. Gregoriadis,et al.  Liposomes as carriers of enzymes or drugs: a new approach to the treatment of storage diseases. , 1971, The Biochemical journal.

[193]  M. Bally,et al.  Uptake of dibucaine into large unilamellar vesicles in response to a membrane potential. , 1985, The Journal of biological chemistry.

[194]  A. McPhail,et al.  Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. , 1971, Journal of the American Chemical Society.

[195]  M. Stuart,et al.  Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery. , 1995, Biochimica et biophysica acta.

[196]  C. Pi Toxicity of some charged lipids used in liposome preparations. , 1983 .

[197]  C Huang,et al.  Studies on phosphatidylcholine vesicles. Formation and physical characteristics. , 1969, Biochemistry.

[198]  M. R. Mozafari,et al.  Nanoliposomes and their applications in food nanotechnology. , 2008, Journal of liposome research.

[199]  V. Torchilin,et al.  Activity of amphipathic poly(ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. , 1991, Biochimica et biophysica acta.

[200]  A. Bangham,et al.  Diffusion of univalent ions across the lamellae of swollen phospholipids. , 1965, Journal of molecular biology.

[201]  S. L. Kumar,et al.  EMULSOMES: AN EMERGING VESICULAR DRUG DELIVERY SYSTEM , 2013 .

[202]  C. Herzog,et al.  Virosome influenza vaccine in children. , 2002, Vaccine.

[203]  Yechezkel Barenholz,et al.  Liposome application: problems and prospects , 2001 .

[204]  S. Clerc,et al.  Loading of amphipathic weak acids into liposomes in response to transmembrane calcium acetate gradients. , 1995, Biochimica et biophysica acta.

[205]  Ching-Hsien Huang,et al.  Phosphatidylcholine vesicles. Formation and physical characteristics , 1969 .

[206]  P. Correale,et al.  Efficient delivery of DNA to dendritic cells mediated by influenza virosomes. , 2004, Vaccine.

[207]  M. Bally,et al.  Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes , 1997, Cancer Chemotherapy and Pharmacology.

[208]  N. Rooijen,et al.  Liposomes in immunology: multilamellar phosphatidylcholine liposomes as a simple, biodegradable and harmless adjuvant without any immunogenic activity of its own. , 1980 .

[209]  N. Mishra,et al.  Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate. , 2009, International journal of pharmaceutics.

[210]  V. Kochupillai,et al.  Encapsulation in Cationic Liposomes Enhances Antitumour Efficacy and Reduces the Toxicity of Etoposide, a Topo-Isomerase II Inhibitor , 2001, Pharmacology.

[211]  G. Gregoriadis The Carrier Potential of Liposomes in Biology and Medicine , 1976 .

[212]  P. Artursson,et al.  Preparation and evaluation of sterically stabilized liposomes: colloidal stability, serum stability, macrophage uptake, and toxicity. , 1990, Journal of pharmaceutical sciences.

[213]  A. Florence,et al.  Liposomes in drug delivery. Clinical, diagnostic and ophthalmic potential. , 1993, Drugs.

[214]  D. Needham,et al.  The “Stealth” Liposome: A Prototypical Biomaterial , 1996 .

[215]  O. Katare,et al.  Topical treatment in vitiligo and the potential uses of new drug delivery systems. , 2010, Indian journal of dermatology, venereology and leprology.

[216]  V. Torchilin,et al.  Which polymers can make nanoparticulate drug carriers long-circulating? , 1995 .